Kidney Transplant Function in Recipients from Deceased Donors with COVID-19
Journal of Clinical Medicine · 25.06.2026 · 15 (13) · 4955
DOI: 10.3390/jcm15134955 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.06.2026. Verfasst von Mengmeng Ji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO 63110, USA. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
During the COVID-19 pandemic, uncertainty regarding the safety of kidneys from COVID-19-positive donors led to a reduction in kidney transplants and increased organ non-use in the United States. This study aims to evaluate whether donor COVID-19 positivity is associated with one-year post-transplant estimated glomerular filtration rate (eGFR) among kidney transplant recipients.
Methods
This retrospective cohort study used data from the United States Organ Procurement and Transplantation Network (OPTN) 2020–2024. Donor COVID-19 status was determined by the SARS-CoV-2 nucleic acid amplification technique (NAT) and antibody test results. The main outcome was recipients’ one-year eGFR, estimated by the CKD-EPI 2021 formula. Linear regression models were used to compare the mean one-year eGFR among donor COVID-19 groups, adjusted by inverse probability of treatment weights. Interaction terms of donor acute kidney injury status and race were assessed to evaluate effect modification.
Results
Among 38,199 included kidney transplant recipients, 1090 (2.9%) received kidneys from donors with active COVID-19 infection, 423 (1.1%) from donors with resolved infection, and 36,686 (96.0%) from COVID-19-negative donors. After weighting and adjustment, there was no significant difference in one-year eGFR for recipients of kidneys from donors with active COVID-19 (mean difference, 0.05 [95% CI, −1.08 to 1.18]) or resolved infection (mean difference, −0.27 [95% CI, −2.19 to 1.64]) compared with COVID-19-negative donors. Neither donor AKI nor donor race modified the association between donor COVID-19 status and one-year eGFR.
Conclusions
This study suggests that kidneys from COVID-19-positive donors may be a viable option without compromising short-term allograft function as measured by 1-year eGFR.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
- Division of Nephrology, Washington University School of Medicine in St. Louis, 660 Euclid Ave., Mail Stop 8126-05-06, St. Louis, MO 63110, USA.
- Division of Nephrology, Saint Louis University, St. Louis, MO 63104, USA.
- Division of Nephrology, University of Arizona, Tucson, AZ 85719, USA.
ORCID-Profile: Mengmeng Ji, Dema Yaseen Alsabbagh, Siobhan Sutcliffe, Krista L Lentine, Su-Hsin Chang
Zitieren
APA
Ji, M., Yaseen Alsabbagh, D., Sutcliffe, S., Merzkani, M., Lentine, K. L., Tanriover, B., Chang, S. H., & Alhamad, T. (2026). Kidney Transplant Function in Recipients from Deceased Donors with COVID-19. Journal of Clinical Medicine, 15(13), 4955. https://doi.org/10.3390/jcm15134955
Vancouver
Ji M, Yaseen Alsabbagh D, Sutcliffe S, Merzkani M, Lentine KL, Tanriover B, et al. Kidney Transplant Function in Recipients from Deceased Donors with COVID-19. Journal of Clinical Medicine. 2026;15(13):4955. doi:10.3390/jcm15134955
BibTeX
@article{Ji2026,
author = {Ji, Mengmeng and Yaseen Alsabbagh, Dema and Sutcliffe, Siobhan and Merzkani, Massini and Lentine, Krista L and Tanriover, Bekir and Chang, Su-Hsin and Alhamad, Tarek},
title = {Kidney Transplant Function in Recipients from Deceased Donors with COVID-19},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {13},
pages = {4955},
doi = {10.3390/jcm15134955}
}
EUVIMED